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Background & Aims: Mice lacking epidermal growth fac-
tor (EGF), transforming growth factor a, and amphiregu-
lin were used to identify roles for these EGF receptor
(EGF-R) ligands in gastrointestinal development and mu-
cosal integrity. Methods: Gastrointestinal tract develop-
ment was examined in knockout mice and correlated
with expression of EGF-R protein and EGF family mem-
bers throughout the gut. Crossfostering experiments ad-
dressed roles of maternal- and neonatal-derived ligands
in pup growth and intestinal development. Cysteamine-
induced ulceration in EGF2/2 mice was used to examine
its role in mucosal cytoprotection. Results: Neonatal
mice lacking all 3 ligands were growth retarded, even
when reared by wild-type dams; conversely, lack of ma-
ternal ligands transiently impaired wild-type pup growth.
Triple null neonates displayed spontaneous duodenal
lesions, and ileal villi were truncated and fragile with
reduced cellular proliferation in the crypts. However,
maturation of digestive enzymes was unaffected. Adult
EGF2/2 mice displayed more severe lesions in response
to cysteamine treatment compared with wild-type coun-
terparts, although triple null mice were not more sus-
ceptible to dextran sulfate sodium–induced colitis, sug-
gesting a differential role for these ligands in the injury
response. Conclusions: EGF-R ligands are required for
development and mucosal maintenance in mouse small
intestine. Both maternal and neonatal sources of growth
factors are required for optimal pup growth.
Epidermal growth factor receptor (EGF-R) (also knownas ERBB1) and its ligands are implicated in devel-
opment and homeostasis of the gastrointestinal tract.
The 6 activating ligands include: epidermal growth fac-
tor (EGF), transforming growth factor (TGF)-a, amphi-
regulin (AR), heparin-binding EGF (HB-EGF), beta-
cellulin (BTC), and epiregulin (EPR).1 Ligand binding
induces EGF-R dimerization, activates the intrinsic ty-
rosine kinase, and couples the receptor to downstream
signaling pathways controlling cell proliferation, differ-
entiation, survival, or motility. EGF-R functions as part
of a network, forming heterodimers with 3 related pro-
teins, ERBB2/c-neu, ERBB3, and ERBB4, and 3 of the
EGF-R ligands, HB-EGF, BTC, and EPR, also directly
bind ERBB4.2,3 Although EGF, TGF-a, and AR only
bind EGF-R, they can nevertheless produce quantita-
tively or qualitatively distinct biological responses.4,5
Components of the EGF-R signaling system are ex-
pressed in the gut, and at least some of the ligands are
present in saliva and milk.6,7 Suggestive of important
roles in gut ontogeny, exogenous EGF or TGF-a are
strong inducers of mucosal growth,8–10 and intestinal
hyperplasia was observed in transgenic mice overexpress-
ing TGF-a.11 Additionally, numerous reports raise the
possibility that EGF-R signaling might influence intes-
tinal maturation in rodents,12 although it remains un-
certain whether effects of EGF on disaccharidase activi-
ties are physiologic. In the mature gut, activated EGF-R
may function in repair because numerous reports show
that exogenous EGF or TGF-a ameliorates mucosal dam-
age in chemical models.13 EGF, TGF-a, and EGF-R are
each induced at sites of gastrointestinal wounding14 and
may regulate trefoil expression as part of the healing
response.15 Finally, the EGF-R system may have other,
nonmitogenic effects on gastrointestinal physiology that
include regulation of gastric acid and mucus secretion, as
well as control of intestinal blood flow and motility.13
Surprisingly, mice lacking TGF-a, EGF, or AR indi-
vidually display no overt gastrointestinal phenotypes,
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EGF, heparin-binding EGF; ITF, intestinal trefoil factor; mRNA, messen-
ger RNA; RT-PCR, reverse-transcription polymerase chain reaction;
TGF, transforming growth factor.




perhaps because of the redundancy of EGF-R ligands.16–18
In addition, multiple lines of mice lacking EGF-R showed
only mild gastrointestinal abnormalities at late gesta-
tion.19,20 However, on a Swiss-Webster background, loss
of EGF-R resulted in a dramatic intestinal phenotype in
neonates that was characterized by a hemorrhagic intes-
tine with short, sparse villi.21 Despite having no overt
gut phenotype, mice lacking TGF-a or harboring a
kinase-defective EGF-R (Waved-2)22 were more sensitive
to dextran sulfate–induced colonic injury23 and showed
impaired adaptation after small bowel resection,24 re-
spectively. These results lend further support to roles for
EGF-R and its ligands in aspects of gut development and
homeostasis.
In the present report, we examine gastrointestinal
defects in triple null mice that simultaneously lack AR,
EGF, and TGF-a (designated aaeett mice18). These mice
are growth retarded, but viable and fertile. We report
here that the duodenum of aaeett weanling mice is prone
to spontaneous ulceration, likely related to decreased
mucin production, and that in the ileum, villi seem
truncated and fragile concomitant with decreased DNA
synthesis in the crypts. We further show that adult mice
lacking only EGF develop more severe duodenal lesions
in response to cysteamine treatment than their wild-type
counterparts. These findings provide important genetic
evidence of roles for EGF, TGF-a, and AR in aspects of
gastrointestinal development and homeostasis.
Materials and Methods
Animals
All mice18 were maintained on a mixed genetic back-
ground of C57BL/6 and 129/SvJ strains through crosses of like
genotype mice. Mice had free access to water and Purina (St.
Louis, MO) lab chow in a climate controlled environment and
were killed by CO2 asphyxiation, in accordance with Institu-
tional Animal Care and Use Committee procedures. Tissues
were fixed in 10% buffered formalin and sectioned by the
UNC Histopathology Core Facility.
Fasted, 4–6-month-old adult female mice were adminis-
tered cysteamine by gavage at a dose of 500 mg/kg and killed
24 (n 5 32 wild-type, 33 AAeeTT mice) or 48 hours (n 5 25
wild-type, 24 AAeeTT mice) later. Duodenal lesions were
observed by stereomicroscopy of opened mucosal surface and
scored as indicated in a blind comparison. Histologic sections
encompassing lesions were used to reevaluate scores.
Molecular Analyses
RNA was isolated from fresh tissues with Trizol (BRL,
Grand Island, NY). Low-cycle number reverse-transcription
polymerase chain reaction (RT-PCR) assays (20–25 cycles)
used the following primers: TGF-a, (F) GTGGCTGCAG-
CACCCTGCGCT, (R) GATCAGCACACAGGTGATAAT-
GAGGAC; EGF, (F) GCAACTCCGTCCGGGCGAGGA, (R)
GAAGATGACTGTGGTCCCGGG; AR, (F) GCCATTATG-
CAGCTGCTTTGGAGC, (R) TGTTTTTCTTGGGCTTAA-
TCACCT; HB-EGF, (F) ATGAAGCTGCTGCCGTCGGT-
GATGCTGA, (R) GGTATCTGCACTCCCCGTGGATGC;
BTC, (F) ATGGACCCAACAGCCCCGGGTAGCAGTG, (R)
TCGCTCACACCGAGCCCCAAAGTA; EPR (F) GACCTG-
TGGCAGCACTGGGTCCCC, (R) ATCATGCATCCCAGG-
AGAATCCGA; EF-1a, (F) AGCGTGGTATCACTATTGA,
(R) ATCTTTGCGGGTGACTTTC; intrinsic factor, (F) CAT-
GGAGAACTCGGTGACTG, (R) CTCCTGTGTCCACATT-
GAAG; and carbonic anhydrase, (F) ATGGAGCAAGCTG-
TATCCCATTGC, (R) GAGCCATGGTCGTTTCAGTTGC.
Ligand complementary DNA (cDNA) probes used were de-
scribed25; control probes were radiolabeled internal 50-base
oligonucleotides. For Northern blots, a mouse sucrase-isomal-
tase probe was derived by PCR amplification of the 39 UT
region (GenBank #AI641904) using primers (F) CGTTGG-
ATGCAAGTTGGAGC and (R) GGTAGTCAAACCATCG-
AGCC, and verified by sequencing. A rat lactase26 cDNA was
kindly provided by Dr. Robert Montgomery, Tufts University.
Western blots were performed as described25 after determining
protein concentrations using the BioRad Protein Assay (Bio-
Rad, Hercules, CA). The intestinal trefoil factor (ITF) antibody
was generously provided by Dr. Andrew S. Giraud, University
of Melbourne.
Statistical Analysis
Results are expressed as mean 6 SEM. Crossfostering
data were analyzed by random coefficient modeling, using
PROC MIXED (SAS software version 8.0, Cary, NC); other
data were analyzed by the Wilcoxon signed-rank, the Fisher
exact, and x2 tests (P , 0.05 considered significant). All
statistical analyses were performed by the UNC Lineberger
Comprehensive Cancer Center Biostatistics Core.
Results
Mice Lacking AR, EGF, and TGF-a Are
Growth Retarded
We previously noted that postnatal growth of
triple null (aaeett) pups was impaired relative to wild-
type counterparts.18 We further showed that growth of
triple hemizygous, (AaEeTt) pups born to aaeett dams
was retarded, but not as severely, suggesting a role for
both maternal- and neonatal-derived growth factors. To
corroborate this, we performed crossfostering experi-
ments in which aaeett pups were nursed by wild-type
dams and wild-type pups were reared by aaeett dams.
These experiments distinguish between potential contri-
butions of reduced milk quantity and/or quality caused
by impaired aaeett mammary gland development vs.
elimination of neonatal growth factors. We selectively
used aaeett dams that successfully weaned their first litter
(the majority do not); these dams had approximately
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50% ductal development when killed upon litter wean-
ing. This strategy resulted in a higher frequency of pup
survival than occurs with random aaeett dams (.90% vs.
25%18). For crossfostering, dams were provided with
completely new, mixed litters composed of 3 pups of each
genotype. Small litter size encouraged equal access to milk,
and mixed litters controlled for nurturing behavior.
Although not apparent in Figure 1, the average
weights of newborn aaeett pups were slightly reduced
relative to that of wild-type pups (1.33 6 0.02 vs.
1.43 6 0.01 g), a statistically significant (P 5 0.0001)
difference. However, this difference became more exag-
gerated, resulting in a 40% reduction in the body weight
of aaeett pups by 3 weeks, the time of weaning. Signif-
icantly, aaeett body weight was only partially restored
when these pups were nursed by wild-type dams; con-
versely, wild-type pups fed aaeett milk had reduced body
weights, relative to the wild-type control pups. Thus,
consistent with our earlier results, optimal postnatal
growth required both maternal and pup sources of li-
gands; loss of either was deleterious. The difference in
body weights diminished with age: by 7 weeks, aaeett
weights were 15% reduced relative to wild-type, and the
influence of the dam’s genotype was no longer apparent
(data not shown).
Triple Null Mice Display Duodenal Lesions
Because a large literature implicates both milk-
borne and endogenous EGF family members in gut
development, and one line of EGF-R null mice displayed
severe intestinal disintegration,21 we examined aaeett
mice for gastrointestinal abnormalities as a possible ex-
planation for the observed growth retardation. Although
most compartments of the aaeett gut displayed normal
morphology, notable defects were observed in the duo-
denum and ileum. In the duodenum, spontaneous lesions
affecting mucosal integrity were observed in ;50% of
samples. These varied from mild erosions and ulcerations
(Figure 2A, a–c) to occasional severe perforations (Figure
2A, a and d).
It has been suggested that EGF family members are
involved in the regulation of cytoprotective mucus se-
cretion in the gastrointestinal tract,13 and TGF-a treat-
ment increases mucin levels in the stomach.27 To
evaluate mucin production, we compared Mayer’s muci-
carmine staining of wild-type and aaeett duodenum.
Most aaeett villous goblet cells stained less robustly with
mucicarmine, suggesting they are producing lower
amounts of mucin (Figure 2B; compare arrowheads).
Additionally, decreased cytoprotection in the aaeett du-
odenum is likely related to the fact that the number of
villous goblet cells was decreased 32% relative to wild-
type villi (n 5 15 well-oriented villi/mouse, 3 mice/
genotype). Neither spontaneous lesions nor altered mu-
cin staining were observed in mice lacking any pair-wise
combination of AR, EGF, and TGF-a (data not shown),
indicating either that all 3 contribute to cytoprotection
normally, or that 1 or more serve this function in re-
sponse to loss of physiologically relevant ligands.
Finally, because EGF-R signaling may also regulate
the production of trefoils, a peptide family critical for
mucosal defense and ulcer healing,28–31 and because tre-
foils and mucins may be coregulated,32 we assessed trefoil
production in triple null mice. Western blots using
anti-ITF28 revealed variably reduced levels of ITF in
proximal, but not distal, small intestine of 3-week-old
aaeett mice compared with wild-type counterparts (data
not shown). However, because ITF is prominently pro-
duced by goblet cells,33 this reduction may largely reflect
the diminished numbers of goblet cells observed in triple
null duodenum. Indeed, remaining goblet cells in wean-
ling aaeett small intestine stained positively for ITF (data
not shown). Reductions in trefoil production, combined
with diminished mucin levels, could account for the
increased incidence of spontaneous lesions in the aaeett
duodenum.
Ileum of aaeett Mice Exhibits Aberrant
Architecture
In the ileum of 3-week-old mice, we observed
altered architecture, owing in part to hypocellularity. In
Figure 1. Growth rates of crossfostered pups. Newborn wild-type (n 5
42) and aaeett (n 5 42) pups were weighed and distributed equally to
wild-type (n 5 7) and aaeett (n 5 7) biparous dams, preserving a
constant litter size of 6 pups. Pup body weight was subsequently
determined at weeks 1, 2, and 3. Survival at week 3 was 81% for
aaeett pups nursed by wild-type dams, 100% for wild-type pups reared
by aaeett dams, and 93% for each of the 2 remaining groups. Al-
though not apparent, the average aaeett birth weight was 7% reduced
relative to that of wild-type pups, a small but statistically significant
difference. Differences between the control (F; }) and crossfostered
(■; Œ) groups were statistically significant (a , 0.05), but the differ-
ence between the experimental, crossfostered groups was not.
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contrast to the smooth finger-like projections of wild-
type ileum (Figure 3A, a), aaeett villi (Figure 3A, c) were
dramatically stunted. They also appeared fragile with
jagged or sheared tips (Figure 3A, d; inset), and fractured
villi were often observed in the lumen. When measured
at 403 magnification, the average villus height in aaeett
ileum was reduced 47% relative to wild-type (218.26 6
2.73 vs. 116.09 6 2.48 mm; n 5 20 well-oriented
villi/mouse, 5 mice/genotype). We also note that the
muscularis mucosa layer of aaeett ileum was frequently
reduced in thickness compared with the wild-type coun-
terpart (Figure 3A, b and d). The significance of this
observation, and specifically whether it reflects general
hypoplasia in this tissue or instead indicates that the 3
EGF-R ligands promote growth of intestinal smooth
muscle cells, is unclear. These defects were transient in
nature because ileum from 5-week-old aaeett mice ap-
peared histologically normal with only a slight (;11%)
reduction in villus height (data not shown). Similar
defects were observed in 3 of 9 aaeett pups reared by
wild-type dams, whereas ileum from 12 wild-type pups
nursed by aaeett dams appeared normal. Consistent with
the morphologic results, the weight/length ratio of the
small intestine was reduced 37% in aaeett pups nursed
by like dams, improved modestly when they were fed
wild-type milk, but was unaffected in wild-type pups
regardless of the milk source (Table 1). Collectively,
these various findings reveal a requirement for neonatally
derived EGF-R ligands in establishment or maintenance
of ileum architecture.
The hypocellularity of aaeett ileum could be caused by
decreased cell proliferation or increased apoptosis and/or
cell sloughing. As assessed by BrdU incorporation,
37.9% 6 2.8% of crypt epithelial cells were proliferat-
ing in 3-week-old wild-type ileum, a value in close
agreement with a published report,34 but only 22% 6
0.3% of cells were proliferating in counterpart aaeett
ileum (Figure 3B). No differences in BrdU staining were
observed in the aaeett duodenum or jejunum, consistent
with the normal appearance of villi in these segments.
Apoptosis, as measured by the TUNEL assay, was not
appreciable in the ileum of either wild-type or aaeett
mice at this age. Hence, reduced cell proliferation likely
accounts for the observed hypocellularity, although in-
creased cell sloughing may contribute.
Functional Maturation of the Small
Intestine Is Not Affected in Triple Null Mice
Coordinated with weaning, the small intestine
undergoes a critical functional switch from expression of
digestive enzymes required for a milk-based diet to adult
enzymes necessary for the digestion of solid food. EGF-R
ligands have been implicated in this process of intestinal
maturation.12 Thus, we compared expression of lactase
and sucrase-isomaltase genes in the jejunum because it
expresses high levels of these enzymes and its architec-
ture was normal in aaeett mice. Northern blots showed
that peak levels of messenger RNAs (mRNAs) encoding
lactase and sucrase-isomaltase were similar in wild-type
and aaeett mice (Figure 4). Moreover, lactase mRNA
levels were similarly reduced in jejunum of both geno-
types at 3 weeks of age, whereas sucrase-isomaltase
mRNA levels similarly increased from barely detectable
levels at 2 weeks of age (data not shown), suggesting that
both the timing and extent of maturation was unaffected
by loss of the 3 EGF-R ligands.
EGF-R Ligands Are Broadly Expressed
in the Gut
Although the defects observed in the aaeett duo-
denum and ileum resemble aspects of the phenotypes
produced by EGF-R deficiency in an outbred mouse
line,21 they are focal and less severe, consistent with
expression of remaining receptor ligands in the gut. Ex-
pression of certain ligands, principally EGF and TGF-a,
has been studied in human and rodent gastrointestinal
tracts, but the family has not been comprehensively
surveyed in mice. To analyze expression of the 6 ligands
throughout the gut of multiple 3-week-old animals, we
used a semiquantitative RT-PCR assay,25 normalizing
the input cDNA to yield comparable amplification of
elongation factor 1a transcripts.35 Validating the assay,
intrinsic factor36 and carbonic anhydrase 137 transcripts
were highly localized to samples respectively derived
from stomach and colon as expected (Figure 5). In
marked contrast to intrinsic factor and carbonic anhy-
drase 1 mRNAs, transcripts for all 6 EGF-R ligands were
found throughout the gut, although some preferential
expression was observed. For example, although levels of
TGF-a and AR transcripts were comparable in most
tissues, EGF, BTC, and EPR mRNAs were enriched in
stomach, and HB-EGF transcripts were elevated in the
small intestine (Figure 5). The finding that HB-EGF,
BTC, and EPR are broadly expressed in the gut provides
a possible explanation for the milder phenotype of aaeett
vs. EGF-R null mice but does not account for the focal
nature of aaeett defects.
In addition to comparing ligand expression, we eval-
uated EGF-R protein levels in wild-type and aaeett mice
over the course of postnatal gut development, including
the early phase of crypt organization and villus extension.
At the times indicated in Figure 6, EGF-R protein was
immunoprecipitated from independent samples of prox-
imal or distal small intestine, or colon, and then immu-
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Figure 2. Morphology of wild-type and aaeett duodenum. (A) Sections of duodenum from 3-week-old wild-type (a) and aaeett (b–d) mice stained
with H&E. Spontaneous lesions (boxed) in specimens from triple null weanlings: (b) erosion, (c) ulcer, and (d) perforation. Note that while not
present in (B–D), Brunner’s glands (BG) were observed in other aaeett duodenum sections. Original magnification 403. (B) [see next page]
Sections of duodenum were treated with Mayer’s mucicarmine, which stains nuclei black and mucins pink. Note the decreased number and size
of mucin positive cells (arrowheads) within the aaeett villi. Original magnification 2003.
Figure 3. Morphology of wild-type and aaeett ileum. (A) Sections of ileum from 3-week-old (a, b) wild-type and (c, d) aaeett mice were stained
with H&E and viewed at low (403; a, c) or high (1003; b, d) magnification. Note that in comparison to those of wild-type ileum, the villi in aaeett
ileum appear stunted with ragged tips (inset). Also, note the reduced thickness of the muscularis mucosa layer in aaeett ileum. (B) [see next
page] Mice were injected intraperitoneally 1 hour before death with 50 mg/kg BrdU solution (Amersham Pharmacia Biotech, San Francisco, CA).
BrdU incorporation in the ileum was visualized using BrdU antibody (Dako, New South Wales, Australia) and the ABC staining kit (Santa Cruz,
Santa Cruz, CA). Results from 4 3-week-old (a, b) wild-type or (c, d) aaeett mice are shown. Note that BrdU-positive cells (examples indicated by
arrowheads) are largely restricted to the crypts, with fewer positive cells detected in aaeett ileum. Original magnification 1003.
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Figure 2B.
Figure 3B.
noblotted using a distinct antibody. The EGF-R protein
band was confirmed by showing that it comigrated with
(1) the prominent receptor band in samples of A431 cells
and (2) a phosphotyrosine-containing protein detected
sequentially by antiphosphotyrosine, 4G10 (Upstate
Biotechnologies, Lake Placid, NY; data not shown). Fig-
ure 6 shows that EGF-R protein levels increased in both
the proximal and distal halves of the small intestine of
wild-type mice from none to barely detectable levels at
day 14, to readily detectable levels by day 21. On the
other hand, EGF-R levels were generally higher in the
colon, and were detectable at day 2. They nevertheless
increased from this time point to near maximal levels by
day 7. These results agree closely with previous detection
of EGF-R in the rat small intestine by Western blot38
and in the rodent gut by binding of radiolabeled li-
gand.39,40
Interestingly, the ontogeny of EGF-R protein levels in
the aaeett small intestine was the mirror image of that in
wild-type tissue. Thus, EGF-R protein was consistently
detected at day 2 in proximal and especially distal por-
tions of the aaeett small intestine, but then declined
thereafter and was generally nondetectable by day 21
(Figure 6). Increased early receptor levels could be caused
by diminished receptor down-regulation in the aaeett
intestine, although an interesting possibility is that
EGF-R is up-regulated as part of a compensatory re-
sponse to loss of 3 of its ligands. In contrast, the time
course of EGF-R expression in the aaeett colon closely
matched that in the wild-type tissue. The deficiency of
EGF-R in weanling aaeett small intestine is intriguing;
it may be explained by a loss of ligand-dependent auto-
crine loops that normally induce receptor expression.7 In
light of the EGF-R phenotype, it raises the question as to
why more severe phenotypes are not observed in the
3-week-old aaeett intestine.
Enhanced Susceptibility of EGF-Null
Duodenum to Cysteamine-Induced
Lesions, but Not to Dextran Sulfate
Sodium–Induced Colitis
As noted above, weanling aaeett duodenum is
susceptible to spontaneous erosion and ulceration. We
pursued these results by examining the role of EGF in
intestinal cytoprotection because previous reports have
described protective roles for EGF in various models of
experimentally induced ulceration.13 EGF null mice
(AAeeTT) were treated with the ulcerogen cysteamine,
which selectively acts in the duodenum and has been
shown to induce Brunner’s glands to deplete their mucus
and EGF stores.41,42 Preliminary experiments established
an effective but generally nonlethal dose of cysteamine
that typically induced a single lesion per mouse.
Groups of fasted adult AAeeTT and wild-type mice
dosed by cysteamine gavage (500 mg/kg) were killed 24
or 48 hours later, and duodenal lesions scored both
grossly and histologically as either erythremas, erosions,
shallow/focal ulcers, ulcers, or perforations. At both time
points, cysteamine treatment produced more severe le-
sions (either ulcers or perforations) in AAeeTT mice
(Figure 7). Thus at 24 hours, 25 of 33 AAeeTT mice
suffered ulcers or perforations, whereas only 12 of 32
wild-type mice had lesions of this severity (P 5 0.0018).
This trend was also present at 48 hours, although not
statistically significant. These results, reproduced in 6
pilot experiments, provide important genetic evidence
for a cytoprotective role for EGF in the adult duodenum.
We also examined the susceptibility of 6-month-old
male aaeett colons to colitis induced by dextran sulfate
sodium (DSS) administered ad libitum (1% or 3% in
drinking water for 7 days). At both doses, no significant
differences were observed between the 2 genotypes (n 5












Wild-type pups:wild-type dams (n 5 11) 9.6 6 0.3 528 6 44 27.6 6 0.7 19 0/9
Wild-type pups:aaeett dams (n 5 17) 7.9 6 0.2 519 6 29 26.5 6 0.4 19 0/12
aaeett pups:aaeett dams (n 5 16) 5.8 6 0.3 287 6 18 22.7 6 0.6 12 6/12
aaeett pups:wild-type dams (n 5 11) 6.7 6 0.4 362 6 28 24.4 6 0.7 14 3/9
NOTE. Crossfostering was performed as described in Results, and data were collected at 3 weeks of age.
aSmall intestine was removed from pyloric to cecal junctions and contents flushed with phosphate-buffered saline. Lengths were determined on
extended small intestines.
bVillus height measurements were performed using light microscopy and computer-assisted morphometry and were considered reduced if the
average height of 20 well-oriented villi was at least 30% smaller than wild-type values. Histologic assessment was performed on a subset of
animals in each case.
cThe difference in the number of mice with reduced villus height, comparing aaeett pups:aaeett dams and wild-type pups:wild-type dams, was
statistically significant (P 5 0.0018). However, there was no significant difference between aaeett pups:aaeett dams and aaeett pups:wild-type
dams (P 5 0.6605).
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6 each) from day 1 through 7 with regard to body weight
loss, stool consistency, or hemoccult assay (data not
shown). Moreover, disease activity index scores43 revealed
no statistically significant differences between the 2
groups at either dose.
Discussion
The phenotypes described here provides genetic
proof of important roles for EGF, TGF-a, and AR in
gastrointestinal development and homeostasis. These de-
fects, namely spontaneous ulceration and shorter, more
fragile villi, are reminiscent of those of newborn EGF-R
null mice in a Swiss-Webster line.21 However, they differ
in their restriction to specific segments of the gut and in
their amelioration with age in survivors. (Note that the
majority of aaeett pups born to uniparous aaeett dams die
within 1–2 days of birth; the survival rate was higher in
the present study because of preselection of nursing-
competent dams.) Whereas EGF-R loss results in a ne-
crotizing enterocolitis-like phenotype with eventual dis-
integration of the intestine in 1–3-week-old animals and
death from wasting, in the present study most triple null
mice survived to adulthood with relatively mild growth
retardation. Although it remains to be established
whether intestinal disintegration in EGF-R knockout
mice is a primary consequence of receptor loss within the
gut, these differences are nevertheless consistent with
redundant roles for EGF-R ligands and with our finding
that transcripts encoding all 6 EGF family members can
be detected throughout the gut in broad, overlapping
patterns. Collectively, these results suggest that although
previous studies have focused primarily on EGF and
TGF-a, other family members are likely to play impor-
tant roles in the gut. Finally, it is worth noting that no
or only mild gastrointestinal defects were observed, de-
spite progressive neonatal wasting in other lines of
EGF-R null mice.19,20 This could be caused by differen-
tial activation of complementary signaling pathways in
other genetic backgrounds.
As noted, triple null mice are growth impaired rela-
tive to wild-type counterparts. The difference is most
severe at weaning, when the average body weight of
aaeett animals is reduced by 40%, and aaeett weanlings
display higher-than-normal mortality (data not shown).
Triple null mice remain smaller as mature adults, weigh-
ing approximately 85% that of wild-type mice. The basis
for this growth impairment is unknown, but a possible
explanation consistent with the phenotypes of aaeett and
especially EGF-R null21 mice is that lack of endogenous
neonatal growth factors leads to inferior gut develop-
ment, resulting in malabsorption of nutrients and mal-
nutrition. Alternatively, reduced quantity or quality of
Figure 4. Expression of digestive enzyme RNAs. Samples (15 mg) of
total jejunal RNA from independent wild-type or aaeett mice of the
indicated ages were resolved through 1% agarose-formaldehyde gels
and examined by Northern blot using cloned rodent cDNA probes for
sucrase-isomaltase or lactase as described in Materials and Meth-
ods. Even loading was verified by methylene blue staining of the 18s
and 28s ribosomal RNA bands. Transcript sizes are 6.8 kilobase for
lactase and 6.5 kilobase for sucrase-isomaltase.
Figure 5. Expression of EGF family genes in the mouse gastrointes-
tinal tract. Total RNA was prepared independently from the indicated
tissues of multiple 3-week-old wild-type mice and was used to prepare
cDNA. PCR amplification was performed with gene-specific primers
after normalizing the cDNA input to yield similar levels of elongation
factor (EF)-1a product in all samples. Amplified products, resolved on
2% agarose gels, were visualized by Southern blotting using cDNA
probes, except for carbonic anhydrase (CA)-1 and intrinsic factor (IF),
which were detected using internal oligonucleotide probes. Sizes of
amplified products ranged from 200 to 450 bases.
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milk, or a deficiency of EGF family members in milk,
could affect both gut development and pup nourishment.
The results of our crossfostering experiments address
both these possibilities. Thus, optimal pup growth re-
quired both maternal and neonatal sources of growth
factors. Because in our crossfostering experiments, the
observed defects in ileal morphology were principally
correlated with the lack of endogenous neonatal growth
factors, the precise connection between milk-borne li-
gands and pup growth is unclear. Of course, it is possible
that these milk-derived growth factors influence intesti-
nal development or function without affecting gross
architecture. Alternatively, it has been previously sug-
gested that milk-derived growth factor can be absorbed
into the circulation.44
Interestingly, the histologic defects described here
were observed at 3 weeks of age, but not at postnatal days
2, 7, and 14, a time course that agrees with the peak
induction of EGF-R in the small intestine (Figure 6).
This could indicate that EGF family members have an
important role in the gut during the transition from
milk to solid food, although we observed no effect on the
change in relevant digestive enzyme profiles. Perhaps
more likely is that EGF family members are required for
the dramatic increase in crypt cell proliferation during
the third postnatal week that results in a significant rise
in villus height.45 Supporting this, villus length and
crypt cell proliferation were both reduced in the 3-week-
old ileum of triple null mice. The fact that truncated villi
were observed only in the ileum may indicate a specific
requirement for these particular EGF-R ligands in this
segment of the gut, although the respective transcripts
were not selectively expressed in this compartment (Fig-
ure 5). Alternatively, because the onset of enhanced crypt
cell proliferation varies along the proximal-to-distal axis,
failure to detect delayed villus elongation in other seg-
ments may simply be a consequence of the time points
analyzed. Villi in the ileum of mature mice seemed
normal, indicating that the defect resulting from loss of
EGF/TGF-a/AR reflects a delay in villus extension,
rather than a permanent condition. Conceivably, this
recovery is caused by activities of remaining EGF family
members, although we did not observe up-regulation of
the remaining EGF-R ligands.
We observed no obvious phenotype in the adult gut
arising from the loss of the respective EGF family mem-
bers, but our results indicate an impaired cytoprotective
response in both neonatal and adult duodenum. We
detected spontaneous ulcers in roughly half of triple null
weanling samples and aggravated injury from cysteamine
treatment in adult mice lacking EGF alone. These results
extend numerous reports of pharmacologic roles for EGF
family members (particularly EGF) in maintenance of
mucosal integrity by confirming a physiologic require-
ment for these ligands. On the other hand, susceptibility
of the adult aaeett colon to DSS-induced colitis was not
affected by loss of the 3 ligands, a result that contrasts
with reports of increased susceptibility of TGF-a knock-
out and waved-2 mice by Egger et al.23,46 This apparent
discrepancy has several possible explanations. The
TGF-a knockout mice used previously were maintained
on a B6 background, whereas our mice are mixed B6/
129. Additionally, we used older mice of opposite sex
(male). Susceptibility to DSS varied with background
strain and was more severe in male mice.47 Consistent
with these results, the 5% DSS dose used by Egger et al.
was lethal to our male aaeett and wild-type mice. Hence,
the enhanced susceptibility of our mice may have masked
Figure 6. EGF-R protein expression during postnatal gut development. The proximal and distal halves of the small intestine and the full-length
colon were harvested from wild-type (wt) or aaeett mice of the designated ages and total protein prepared as described in Materials and Methods.
Aliquots (500 mg) of total protein were immunoprecipitated with EGF-R antibody ERCT (H. Shelton Earp, University of North Carolina at Chapel
Hill), resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis, and immunoblotted with EGF-R antibody 1005 (Santa Cruz) as
described.25 Exposure times were 1–3 minutes. The position of EGF-R protein is indicated (arrows).
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previously observed differences between the genotypes. A
more severe phenotype in waved-2 mice could be attrib-
utable to the fact that the associated EGF-R defect would
eliminate signaling responses to all EGF family ligands,
and additionally impair activation of related ERBB pro-
teins arising from receptor heterodimerization.
The appearance of spontaneous lesions in the duode-
num of aaeett mice is likely related to the aberrant mucin
staining and reduced ITF protein expression observed in
this tissue. The fact that spontaneous lesions were
present only in the duodenum of aaeett mice is consistent
with observations that mice treated with an EGF-R
inhibitor develop lesions only in the duodenum.48 It may
also reflect the importance of EGF-producing Brunner’s
glands in this segment of the intestine and/or may be
linked to our observation that several EGF family genes
are preferentially expressed in stomach (Figure 5).
Growth factors produced in the stomach could be re-
leased with chyme, where they would be available to
signal to the basolateral EGF-R in the event of duode-
num mucosal damage. The temporal restriction of spon-
taneous lesions to weaning age may reflect a natural
propensity of the duodenum to ulceration at this time,
perhaps related to shifts in diet and gastric or pancreatic
secretions. Alternatively, it could reflect reparative activ-
ities of the remaining ligands, BTC, HB-EGF, and EPR,
in more distal segments of the intestine. This and related
issues will be the subject of future investigation.
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